key: cord-0975501-74662f5d
authors: Khezri, Mohammad Rafi; Moloodsouri, Donya; Hodaei, Darya; Ghasemnejad‐Berenji, Morteza
title: Therapeutic potential of loureirin A against SARS‐CoV‐2 infection
date: 2022-03-31
journal: Phytother Res
DOI: 10.1002/ptr.7453
sha: 3f2a8d82cdbb65080b2d77216767e55a9a840427
doc_id: 975501
cord_uid: 74662f5d

nan

PI3K/AKT signaling pathway is also involved in the activation of inflammatory factors such as nuclear factor kappa B (NF-κB) and activated protein 1 (AP-1) (X. Liu et al., 2014) . Moreover, it is shown that activation of the PI3K/AKT signaling pathway induces fibrosis in different organs, including that of lungs (Saito et al., 2017) . Relevant to this proposed effect of loureirin A on SARS-CoV-2, loureirin A is known as a general PI3K/AKT inhibitor (Hao et al., 2015; Hu et al., 2020) . Although different isoforms of PI3K can have different activities in different organs, more studies are needed to determine the effect of this compound on different isoforms. It is shown that loureirin A suppresses the expression of inflammatory cytokines by inhibiting AKT/NF-κB in an animal model of osteoarthritis (Hu et al., 2020) . Also, in this study, it was shown that loureirin A ameliorates IL-1β induced oxidative stress. Furthermore, oral treatment of myocardial infarction rats with Dragon's Blood led to reduced oxidative stress markers (i.e., superoxide dismutase) and inflammatory mediators (i.e., IL-6 and TNF-α) (Lyu et al., 2022) . However, it can be speculated that PI3K/AKT inhibition by loureirin A, in addition to potentially beneficial antiinflammatory activities, may suppress SARS-CoV-2 entry into the host cells via ACE2 through blockade of clathrinmediated endocytosis.

Moreover, one of the most serious complications of SARS-CoV-2 infection is blood coagulation, which is significantly associated with mortality (Ibrahim & Ellakwa, 2021) . The PI3K/AKT signaling pathway plays a crucial role in coagulopathies during different pathologic conditions through inducing platelet activation and expression of coagulant factors (Khezri, Varzandeh, & Ghasemnejad-Berenji, 2022) .

Interestingly, it is shown that this pathway is involved in SARS-CoV-2-induced coagulopathy (Pelzl et al., 2021) . In this regard, a study by

Antiplatelet activity of loureirin A by attenuating Akt phosphorylation: In vitro studies

Downregulating Akt/NF-κB signaling and its antioxidant activity with loureirin A for alleviating the progression of osteoarthritis: In vitro and vivo studies

SUMO pathway, blood coagulation and oxidative stress in SARS-CoV-2 infection

PI3K/AKT signaling pathway: A possible target for adjuvant therapy in COVID-19

The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy

Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection

A botanical medicine Dragon's blood exhibited clinical antithrombosis efficacy similar to low molecular weight heparin

HIV-1 Nef induces CCL5 production in astrocytes through p38-MAPK and PI3K/Akt pathway and utilizes NF-kB

Dragon's blood from dracaena worldwide: Species, traditional uses, Phytochemistry and pharmacology

Compound Dragon's blood capsule alleviates the degree of myocardial ischemia by improving inflammation and oxidative stress

Platelet activation via PI3K/AKT signaling pathway in COVID-19

Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway

Capivasertib restricts SARS-CoV-2 cellular entry: A potential clinical application for COVID-19

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2